Investigating oral microbiome dynamics in chronic kidney disease and post-transplantation in continuous culture

被引:0
|
作者
Campbell, Paul M. [1 ]
Willmott, Thomas [1 ]
Summers, Angela [2 ]
Knight, Christopher G. [3 ]
Humphreys, Gavin J. [1 ]
Konkel, Joanne E. [4 ]
Augustine, Titus [2 ]
Mcbain, Andrew J. [1 ]
机构
[1] Univ Manchester, Fac Biol Med & Hlth, Sch Hlth Sci, Manchester, England
[2] Manchester Acad Hlth Sci Ctr, Manchester Univ Hosp NHS Fdn Trust, Dept Renal & Pancreat Transplantat, Manchester, England
[3] Univ Manchester, Fac Sci & Engn, Sch Nat Sci, Manchester, England
[4] Univ Manchester, Sch Biol Sci, Fac Biol Med & Hlth, Manchester, England
来源
MICROBIOLOGY SPECTRUM | 2024年 / 12卷 / 11期
基金
英国医学研究理事会;
关键词
urea; oral microbiome; kidney transplantation; chronic kidney disease; ANTIMICROBIAL SUSCEPTIBILITY; DENTAL BIOFILMS; PH; BACTERIA; STREPTOCOCCI; ENZYMES; HEALTH;
D O I
10.1128/spectrum.00598-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The oral microbiome is influenced by environmental factors in chronic kidney disease and following kidney transplantation affecting microbial composition, which may have implications for health and recovery. A major driver of oral microbiome perturbation is the accumulation of urea in saliva. We have modelled increased salivary urea concentrations associated with CKD and subsequent reductions that may occur post-transplantation. Oral microbiota were established in constant-depth film fermenters by inoculation with saliva. Duplicate validation runs were maintained with artificial saliva with baseline urea concentrations (0.205 mg/mL) for 21 days. Triplicate treatment runs were then done with baseline urea for 10 days (healthy phase) before urea was increased for 10 days to reflect CKD concentrations (0.92 mg/mL) (CKD phase). This was followed by reversion to baseline urea concentrations (post-transplant phase). Biofilms in primary validation runs reached dynamic stability within 5 days according to viable counting. DNA sequence data indicated minimal taxonomic variation over time and between low and high urea treatments despite background noise indicating changes in bacteria belonging to the family Gemellaceae and the genera TG5 and Leptotrichia. Significant differences in alpha and beta diversity occurred between low and high urea states but not following reversion to a low urea environment. Increased abundance of the TG5 was detected in late model phases, despite apparent count stability, and independent of changes in urea concentrations.IMPORTANCEThis study investigates dynamic changes in the oral microbiome associated with changes in salivary urea concentration, an important factor in chronic kidney disease (CKD). The in vitro system modeled increased urea concentrations and subsequent reductions post-transplantation. The study provides insight into the oral microbial shifts during different simulated clinical phases. Understanding these dynamics is crucial for advancing our comprehension of CKD-associated oral microbiome variations and their potential impact on patient well-being and recovery. This study investigates dynamic changes in the oral microbiome associated with changes in salivary urea concentration, an important factor in chronic kidney disease (CKD). The in vitro system modeled increased urea concentrations and subsequent reductions post-transplantation. The study provides insight into the oral microbial shifts during different simulated clinical phases. Understanding these dynamics is crucial for advancing our comprehension of CKD-associated oral microbiome variations and their potential impact on patient well-being and recovery.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Artificial intelligence and liver transplantation: post-transplantation chronic kidney disease prediction
    Carrier, Paul
    Loustaud-Ratti, Veronique
    Debette-Gratien, Maryline
    Maurel, Pauline
    Premaud, Aurelie
    Rousseau, Annick
    Marie, Essig
    Rigaud, Celine
    Silvain, Christine
    Causse, Xavier
    Marquet, Pierre
    Salame, Ephrem
    Woillard, Jean-Baptiste
    JOURNAL OF HEPATOLOGY, 2024, 80 : S387 - S387
  • [2] Post-transplantation dynamics of the immune response to chronic myelogenous leukemia
    DeConde, R
    Kim, PS
    Levy, D
    Lee, PP
    JOURNAL OF THEORETICAL BIOLOGY, 2005, 236 (01) : 39 - 59
  • [3] Post-transplantation bone disease
    Compston, JE
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S48 - S48
  • [4] Post-transplantation bone disease
    Compston, JE
    BIOMARKERS OF DISEASE: AN EVIDENCE-BASED APPROACH, 2002, : 461 - 466
  • [5] Post-transplantation lymphoproliferative disease
    Savage, P
    Waxman, J
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 1997, 90 (08): : 497 - 503
  • [6] Post-transplantation Malignancy After Kidney Transplantation in Turkey
    Keles, Y.
    Tekin, S.
    Duzenli, M.
    Yuksel, Y.
    Yucetin, L.
    Dosemeci, L.
    Sengul, A.
    Demirbas, A.
    Tuncer, M.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (05) : 1418 - 1420
  • [7] Post-transplantation diabetes mellitus in kidney recipients
    Dubois-Laforgue, Daniele
    NEPHROLOGIE & THERAPEUTIQUE, 2017, 13 : S137 - S146
  • [8] CHRONIC KIDNEY DISEASE POST LIVER TRANSPLANTATION
    Jeyamani, Ramachandran
    Libby, John
    Rajiv, Juneja
    Amit, Dutta
    Richard, Woodman
    Alan, Wigg
    IMMUNOLOGY AND CELL BIOLOGY, 2009, 87 (06): : A27 - A27
  • [9] CHRONIC KIDNEY DISEASE POST LIVER TRANSPLANTATION
    Ramachandran, Jeyamani
    John, Libby
    Juneja, Rajiv
    Dutta, Amit K.
    Woodman, Richard
    Wigg, Alan J.
    LIVER TRANSPLANTATION, 2009, 15 (07) : S207 - S207
  • [10] Post-transplantation diabetes in kidney transplant recipients
    Bastos, M
    Baptista, C
    Rodrigues, D
    Ruas, L
    Alves, R
    Freitas, L
    Bastos, C
    Carvalheiro, M
    Mota, A
    Furtado, L
    Ruas, M
    DIABETOLOGIA, 1998, 41 : A225 - A225